Alnylam Pharmaceuticals
ALNY
#1123
Rank
NZ$37.67 B
Marketcap
NZ$281.31
Share price
3.30%
Change (1 day)
-64.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company